REQUEST A DEMO
Total
USD $0.00
Search more companies

Novafarm OOO (Penza) (Новафарм ООО (Пенза)) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novafarm OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Novafarm OOO (Penza) (Новафарм ООО (Пенза)) is an enterprise in Russia, with the main office in Penza. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on February 17, 2022. The latest financial highlights indicate a net sales revenue increase of 125.82% in 2024. Its total assets grew by 243.95% over the same period. In, 2024, the company’s net profit margin increased by 1.93%.

Headquarters
Gagarina, 1
Penza; Penza Oblast; Postal Code: 440039

Contact Details: Purchase the Novafarm OOO (Penza) (Новафарм ООО (Пенза)) report to view the information.

Basic Information
Financial Auditors:
Purchase the Novafarm OOO (Penza) (Новафарм ООО (Пенза)) report to view the information.
Incorporation Date:
February 17, 2022
Company Performance
Financial values in the chart are available after Novafarm OOO (Penza) (Новафарм ООО (Пенза)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
125.82%
Total operating revenue
125.82%
Operating profit (EBIT)
1125.85%
Net Profit (Loss) for the Period
276.4%
Total Assets
243.95%
Total Equity
365.11%
Operating Profit Margin (ROS)
2.63%
Net Profit Margin
1.93%
Return on Equity (ROE)
-18.5%
Debt/Equity
236.71%
Quick Ratio
2.05%
Cash Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?